The Cancer Consortium

Cancer News & Information Center

Saturday, October 31st, 2026

Menu

  • Home
  • Members
    • Travera
    • Soligenix (SNGX)
    • NuView Life Sciences
  • News
    • MEMBER NEWS
    • FINDINGS
    • INDUSTRY
  • INTERVIEWS
    • CEOs
    • KOLs
  • Cancer Types
    • Breast Cancer
    • Cervical Cancer
    • Head and Neck Cancer
  • Database
  • About
    • Altru Cancer
    • Cancer Consortium
    • Newsletter
    • Research
  • RESOURCES
    • Foundations
    • Patient Resources
    • Media Resources

Opko to Acquire Complimentary Diagnostics Firm

By Global Cancer Consortium on June 1, 2007 • ( Leave a comment )

Miami-based Opko Health (formerly known as eXegenics) today announced plans to acquire a diagnostic imaging firm that would compliment its portfolio of ophthalmic therapeutics. The acquisition target, Ophthalmic Technologies (OTI), is a […]

Endocare Raises $7 Million

By Global Cancer Consortium on May 29, 2007 • ( Leave a comment )

Endocare, an Irvine, CA-based company focused on tissue and tumor ablation, has raised $7 million in a private placement of common stock to Seattle-based Frazier Healthcare Ventures. In a statement, Endocare CEO Craig […]

Inovio’s Delivery Technology Boosts Cancer Vax Potency

By Global Cancer Consortium on May 23, 2007 • ( 1 Comment )

Data released yesterday from a study of an experimental prostate cancer vaccine showed that Inovio Biomedical‘s delivery system significantly enhanced the vaccine’s potency. In the Phase I/II study, some patients received the […]

Champions Biotechnology to Buy Biomerk

By Global Cancer Consortium on May 21, 2007 • ( Leave a comment )

Champions Biotechnology, of Arlington, VA, announced today plans to buy Biomerk, a private company formed just last year to develop its trademark Tumorgrafts, a preclinical platform of human cancer tumor immune-deficient mice […]

Robotic Devices Move Into the Mainstream…and Beyond

By Global Cancer Consortium on May 16, 2007 • ( Leave a comment )

Cardiogenesis, an Irvine, CA-based medical device company that specializes in devices that stimulate cardiac angiogenesis, submitted a PMA last week for its minimally invasive Robotic 5.0 PEARL Delivery System. The PEARL, which stands […]

Nanotech Investments Come with Risk

By Global Cancer Consortium on May 7, 2007 • ( Leave a comment )

An article published today by Nanowerk says that today’s hefty investments in nanotechnology come with risk. Nanotech applied to diagnostics has raised hopes that diagnosis will eventually be possible at the cellular […]

Entrepreneurial Activity Spikes in North Carolina

By Global Cancer Consortium on May 4, 2007 • ( Leave a comment )

Life sciences startups are popping up — and looking for money — in the Research Triangle Park section of North Carolina, says an article from today’s The News & Observer. “At least […]

Cliff Notes to the Times’ Diagnostics Special Section

By Global Cancer Consortium on May 2, 2007 • ( Leave a comment )

Yesterday’s New York Times had a special section — a “user’s guide” — on diagnostic testing. It covers asthma, bone disease, cancer, heart disease, obesity, diabetes, AIDS and glaucoma. Don’t have time […]

Posts navigation

‹ Newer 1 … 78 79 80 81 82 83 84 Older ›

INTERVIEWS »

INTERVIEW: Travera CEO Clifford Reid PhD

INTERVIEW: Soligenix CEO Christopher Schaber PhD.

INTERVIEW: Biden Cancer Initiative’s Greg Simon

PROFILES »

Gray Scale Images Convert to Detailed Color Images to Better Diagnose Breast Cancer

New Technology Using Light Therapy Kills Cells with No Side Effects

Real-time, In vivo Imaging Platform to Guide Surgeon During Cancer Surgery

Image result for cancer commons

Cancer Progress Report

Altru Cancer Progress Report June 2019

Subscribe to Cancer Progress Report

 

 

About Cancer Consortium

Members of the Global Cancer Consortium believe that progress occurs through collaboration which can occur through improved information.

This news site aggregates information and profiles of the member companies and organizations.

Its Cancer Progress Report reaches thousands of investors and industry professionals.

Global Cancer Consortium

The Cancer Consortium was formed by the Altru Cancer Project to offer one place to learn about the most promising developments, technologies and companies focused on Cancer.

 

 

  • Top categories: COMPANIES / cancer / Blog / feature2 / NEWS / Featured Articles / MEMBER NEWS / feature1 / Uncategorized / Member Spotlight
  • Top tags: cancer / breast cancer / diagnostics / oncology / prostate cancer / clarient / peter winter / brain cancer / melanoma / immunotherapy
Proudly powered by WordPress | Theme: Broadsheet by Pro Theme Design.